An interview with the winners of the 9th Rise Up Festa, a business support program sponsored by Mitsubishi UFJ Bank, in which our company was selected as the best company, was published on the Bank's website.
Nobuyuki Arakawa, President and CEO, introduces "Development of regenerative medicine products for the treatment of intractable diseases such as blood cancers using in vitro expansion technology of human hematopoietic stem cells" in the article.
External link: Interview with the winners of the 9th "Rise Up Festa"
"Changing the Future with Cell Therapy"
Development of regenerative medicine and other products for the treatment of intractable diseases using in vitro expansion technology of human hematopoietic stem cells.